HPLC quantitation of a very hydrophilic 3-hydroxypyridin-4-one chelator using a simple separation procedure and the baseline file subtraction method

Journal of Chromatographic Science

Volumn 34, Issue 1, 1996, Pages 52-57

  Skinner, Thomas L ^a   Meurer, Kathryn A ^a   Yokel, Robert A ^a,b,c  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORYCTOLAGUS CUNICULUS;

1 (ETHAN 1 OL) 2 METHYL 3 HYDROXYPYRIDIN 4 ONE; 1-(ETHAN-1-OL)-2-METHYL-3-HYDROXYPYRIDIN-4-ONE; CHELATING AGENT; PYRIDONE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METHODOLOGY; RABBIT; RAT; SENSITIVITY AND SPECIFICITY; STATISTICS;

ANIMALS; CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MALE; PYRIDONES; RABBITS; RATS; SENSITIVITY AND SPECIFICITY;

EID: 0029691115     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/34.1.52     Document Type: Article

References (12)

1. R.A. Yokel, A.K. Datta, and E.G. Jackson. Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum. J. Pharmacol. Exp. Ther. 257: 100-106 (1991).
2. R.J. Bergeron, R.R. Streiff, J. Wiegand, G. Luchetta, E.A. Creary, and H.H. Peter. A comparison of the iron-chelating properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine. Blood 79: 1882-90 (1992).
3. P.S. Dobbin, R.C. Hider, A.D. Hall, R.D. Taylor, P. Sarpong, J.B. Porter, G. Xiao, and D. van der Helm. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential. J. Med. Chem. 36: 2448-58 (1993).
4. G.J. Kontoghiorghes, J. Barr, P. Nortey, and L. Sheppard. Selection of a new generation of orally active α-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload. Am. J. Hematol. 42: 340-49 (1993).
5. G.J. Kontoghiorghes, J. Barr, and R.A. Baillod. Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Arzneimittel-forschung 44: 522-26 (1994).
6. J.B. Porter, M. Gyparaki, L.C. Burke, E.R. Huehns, P. Sarpong, V. Saez, and R.C. Hider. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant. Blood 72: 1497-1503 (1988).
7. R.O. Epemolu, S. Singh, R.C. Hider, and L.A. Damani. High-performance liquid chromatographic determination of 1,2-diethyl-3-hydroxypyridin-4-one and its 2-(1-hydroxyethyl) metabolite in rat blood. J. Chromatogr. 573: 178-82 (1992).
8. R.A. Yokel, A.M. Fredenburg, K.A. Meurer, and T.L. Skinner. Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators. Drug Metab. Dispos. 23: 1178-60 (1995).
9. Normal and Reverse Phase High Performance Liquid Chromatography. Chromatography Institute of America, Medfield, MA, 1994.
10. J.L. Fox and M.L. Lamson. RSTRIP: Pharmacokinetic Data Stripping/Least Squares Parameter Optimization, Version 5.0. MicroMath, Inc., Salt Lake City, UT, 1989.
11. R.O. Epemolu, S. Singh, R.C. Hider, and L.A. Damani. Chromatography of 3-hydroxypyridin-4-ones: novel orally active iron chelators. J. Chromatogr. 519: 171-78 (1990).
12. A.M. Fredenburg, R.K. Sethi, D.D. Allen, and R.A. Yokel. The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethyl-, 1,2 diethyl-, and 1-[ethan-1′ol]-2-methyl-3-hydroxypyridin-4-one in the rat. Drug Metab. Dispos. In press.